Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 323, pseudogene (RN7SL323P) is a human non-coding RNA pseudogene derived from the 7SL RNA family, specifically mapping to chromosome 8q12.1[1][5]. The 7SL RNA gene encodes the RNA component of the signal recognition particle (SRP), which functions in directing protein trafficking to the endoplasmic reticulum[7]. However, RN7SL323P is a **pseudogene**—it is a non-functional remnant of 7SL RNA, likely produced by retrotransposition and not believed to generate a stable, functional RNA transcript[3]. Pseudogenes like RN7SL323P typically lack protein-coding potential and do not serve as classical molecular targets (receptors, enzymes, etc.). While recent research suggests that some pseudogenes may play roles in gene regulation (such as acting as competitive endogenous RNAs or sources of regulatory small RNAs), there is no evidence for a specific regulatory or disease-related function of RN7SL323P itself[4]. RN7SL323P is not considered a therapeutic target, biomarker, or safety concern in clinical settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 323, pseudogene (RN7SL323P).